These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9500449)

  • 1. Phospholipase C delta-4 overexpression upregulates ErbB1/2 expression, Erk signaling pathway, and proliferation in MCF-7 cells.
    Leung DW; Tompkins C; Brewer J; Ball A; Coon M; Morris V; Waggoner D; Singer JW
    Mol Cancer; 2004 May; 3():15. PubMed ID: 15140260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine.
    Chakrabarti S; Liu NJ; Gintzler AR
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13686-91. PubMed ID: 14597703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gαq/phospholipase Cβ signaling system represses tau aggregation.
    Garwain O; Yerramilli VS; Romero K; Scarlata S
    Cell Signal; 2020 Jul; 71():109620. PubMed ID: 32247043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatiotemporal Optical Control of Gαq-PLCβ Interactions.
    Ubeysinghe S; Kankanamge D; Thotamune W; Wijayaratna D; Mohan TM; Karunarathne A
    ACS Synth Biol; 2024 Jan; 13(1):242-258. PubMed ID: 38092428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal optical control of Gαq-PLCβ interactions.
    Ubeysinghe S; Kankanamge D; Thotamune W; Wijayaratna D; Mohan TM; Karunarathne A
    bioRxiv; 2023 Aug; ():. PubMed ID: 37609229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma.
    Zhang T; Song X; Liao X; Wang X; Zhu G; Yang C; Xie X
    Biomed Res Int; 2019; 2019():4256524. PubMed ID: 31080817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?
    Cristea S; Sage J
    J Thorac Oncol; 2016 Aug; 11(8):1233-1241. PubMed ID: 27133774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune regulation by phospholipase C-β isoforms.
    Xiao W; Kawakami Y; Kawakami T
    Immunol Res; 2013 May; 56(1):9-19. PubMed ID: 22638704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation.
    Oh YS; Jo NW; Choi JW; Kim HS; Seo SW; Kang KO; Hwang JI; Heo K; Kim SH; Kim YH; Kim IH; Kim JH; Banno Y; Ryu SH; Suh PG
    Mol Cell Biol; 2004 Jun; 24(11):5069-79. PubMed ID: 15143197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism.
    Chan D; Gera L; Stewart J; Helfrich B; Verella-Garcia M; Johnson G; Baron A; Yang J; Puck T; Bunn P
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4608-13. PubMed ID: 11930011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and functional interactions of Galphaq with Rho and its exchange factors.
    Sagi SA; Seasholtz TM; Kobiashvili M; Wilson BA; Toksoz D; Brown JH
    J Biol Chem; 2001 May; 276(18):15445-52. PubMed ID: 11278452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.
    Dohjima T; Ohno T; Banno Y; Nozawa Y; Wen-yi Y; Shimizu K
    Br J Cancer; 2000 Jan; 82(1):16-9. PubMed ID: 10638960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
    Strassheim D; Shafer SH; Phelps SH; Williams CL
    Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors.
    Wylie PG; Challiss RA; Blank JL
    Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):619-28. PubMed ID: 10051431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides.
    Gudermann T; Roelle S
    Endocr Relat Cancer; 2006 Dec; 13(4):1069-84. PubMed ID: 17158754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo.
    Sethi T; Langdon S; Smyth J; Rozengurt E
    Cancer Res; 1992 May; 52(9 Suppl):2737s-2742s. PubMed ID: 1314136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
    Beekman A; Helfrich B; Bunn PA; Heasley LE
    Cancer Res; 1998 Mar; 58(5):910-3. PubMed ID: 9500449
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.